Immatics has filed a notice of a Private Investment in Public Equity (PIPE) offering of securities to raise $35,000,000.00 in Post-IPO Equity.
According to filings with the U.S. Securities and Exchange Commission, Immatics is raising $35,000,000.00 in new funding. About Immatics: Immatics N.V., a clinical-stage biopharmaceutical company, focuses on the discovery and development of potential T cell…